Using machine learning methods to investigate the impact of comorbidities and clinical indicators on the mortality rate of COVID-19
XGBoost outperformed other models making it a viable tool for both emergency and outpatient settings. The study underscores the importance of chronic disease assessment in predicting COVID-19 mortality, revealing some comorbidities such as diabetes mellitus, cerebrovascular disease and chronic lung disease to have protective association with 30-day mortality. These findings suggest potential refinements in current treatment guidelines, particularly concerning high-risk conditions. The integration of federated learning further enhances the model's clinical applicability while preserving patient privacy.
Authors
- Ya‐Ju Hsieh (ORCID: https://orcid.org/0000-0003-2082-9345)
- S.Y. Tsao (ORCID: https://orcid.org/0000-0002-5787-9664)
- Chien‐Chang Lee (ORCID: https://orcid.org/0000-0002-1243-2463)
- Jiun‐Ruey Hu (ORCID: https://orcid.org/0000-0003-1390-508X)
- Wan‐Ting Hsu (ORCID: https://orcid.org/0000-0002-6677-0951)
- S.-A. Chen
Institutions
- Cedars-Sinai Medical Center (US)
- Harvard University (US)
- National Taiwan University (TW)
- Ministry of Health and Welfare (TW)
- National Taiwan University Hospital (TW)
- Cedars-Sinai Smidt Heart Institute (US)
- Brookline Public Schools (US)
Publication Details
- Journal
- Frontiers in Medical Technology
- Published
- 2025-09-22
- DOI
- https://doi.org/10.3389/fmedt.2025.1621158
- Citations
- 1
- Primary Topic
- COVID-19 diagnosis using AI
- Type
- article
- Field-Weighted Citation Impact
- 1.36
Funders
- National Taiwan University Hospital
- National Taiwan University
- National Science and Technology Council
- National Taiwan University Hospital Yunlin Branch